News | February 24, 2026
Bayer introduces chemo-free treatment option for advanced prostate cancer in India
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
This approval builds on the recent transformation RYBREVANT FASPRO brought to lung cancer care
Leading the showcase is FCT iStream, Fujifilm’s latest CT scanner built on a “Less is More” design philosophy
Nucala is the first and only monthly biologic in the EU evaluated in a wide COPD population with an eosinophilic phenotype
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
The guidelines also support reusing tenofovir and abacavir in later regimens for improved outcomes, cost savings, and programmatic efficiency
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
Mepolizumab is the first and only monthly biologic in China tested for COPD patients with blood eosinophil counts (BEC) as low as 150 cells/µL
India’s pharmaceutical sector stands at a pivotal inflection point
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
Subscribe To Our Newsletter & Stay Updated
